BSECompany Update6d ago · 29 Jul 2026, 03:16 am

Please find the enclosed intimation of the Company as per the captioned subject for your reference.

AstraZeneca Pharma India Ltd · 506820

✦ AI Summary

AstraZeneca Pharma India Ltd has submitted a certificate confirming compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

AstraZeneca Pharma India Ltd - 506820 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Attachments (1)

📄

9e562270-48d9-4f63-91cc-2816d9694ab6.pdf

pdf

Download →
View document text
July 29, 2026 The Manager - Listing BSE Limited P J Towers, Dalal Street Fort, Mumbai - 400001 National Stock Exchange of India Ltd. Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai - 400051 Dear Sir/ Madam Sub: Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 We are enclosing herewith the Certificate dated July 27, 2026 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026. Please take the same on record. Thanking you, For AstraZeneca Pharma India Limited Tanya Sanish Company Secretary & Compliance Officer Encl: as above IRMSPL/ASTRA/06SS/JUN/2026 July27,2026 AstraZenecaPharmaIndiaLimited BlockN1,12thFloor ManyataEmbassyBusinessPark RachenahalliOuterRingRoad Bangalore–560045 KindAttn: CompanySecretary&ComplianceOfficer DearMadam, Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Sub: Regulations,2018-Fortheperiod 01.04.2026to30.06.2026 This has reference to the Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, we herebyconfirmthatwehavecompliedwiththefollowingactionswithin15daysofreceiptofcertificate(s)of securityfromthedepositoryparticipantforthepurposeofdematerialization: 1)The securities comprised in the certificate(s) Dematerialized, are listed on the stock exchange or exchangeswheretheearlierissuedsecuritiesarelisted. 2)Mutilatedandcanceledthecertificateofsecurityforwardedbytheparticipants. 3)Substitutedthenameofthedepositoryastheregisteredownerinourrecords. ThankingYou, Yoursfaithfully, ForIntegratedRegistryManagementServicesPrivateLimited Digitally signed by S S GIRIDHARGIRIDHAR Date: 2026.07.27 15:32:05 +05'30' SGiridhar GeneralManager Page:1/1 INTEGRATEDREGISTRYMANAGEMENTSERVICESPRIVATELTD #30, RamanaResidency,4thCross, SampigeRoad, Malleswaram,Bangalore–560003. PhoneNo.:08023460815to818 FaxNo.:08023460819 FixedDepositsrelatedquery EmailID:fd@integratedindia.in/SharesrelatedqueryEmailID:giri@integratedindia.in Regd.Office: 2ndFloor,KencesTowers,No.1,RamakrishnaStreet,NorthUsmanRoad,T. Nagar,Chennai–600017 CIN:U74900TN2015PTC101466;SEBIRegnNo: INR000000544 “Appointmentofanomineeforthesharesheldbyyouisnotanoptionbutyourright!!Pleaseexerciseyourrighttonominate”